Valsartan

Effects of VALsartan On atRIAl Mitral Regurgitation: A Pilot Randomized Controlled Trial

Manganese-enhanced Magnetic Resonance Imaging in Takotsubo Cardiomyopathy

Treating Heart Dysfunction Related to Cancer Therapy With Sacubitril/Valsartan

Neprilysin Inhibition to Reduce Myocardial Fibrosis in Heart Failure With Preserved Ejection Fraction

Sacubitril Valsartan in Preventing the Recurrence of Atrial Fibrillation After Ablation in Elderly Hypertensive Patients With Atrial Fibrillation

A Drug-Drug Interaction Study of HDM1002 and Metformin, Empagliflozin, Midazolam, Valsartan, and Warfarin

A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia

Phase 3 Trial to Evaluate the Efficacy and Safety of CKD-202A

Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 1

Role of ARNi in Ventricular Remodeling in Hypertensive LVH

24 Hour Ambulatory Cardiac Oxygen Consumption

Bariatric Surgery and Pharmacokinetics of Valsartan

LCZ696 in Advanced LV Hypertrophy and HFpEF

Changes in NT-proBNP, Safety, and Tolerability in HFpEF Patients With a WHF Event (HFpEF Decompensation) Who Have Been Stabilized and Initiated at the Time of or Within 30 Days Post-decompensation (PARAGLIDE-HF)

A Phase III Clinical Trial Evaluating the Efficacy and Safety of Valsartan/Levamlodipine (SYH9056) Tablets In Hypertensive Patients

Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction

Sacubitril/Valsartan Treats Patients With Essential Hypertension and Type 2 Diabetic Nephropathy

Study to Evaluate the Efficacy and Safety of SPH3127 In Patients With Mild-moderate Essential Hypertension

The Effects of Sacubitril/Valsartan on Cardiac Oxygen Consumption and Efficiency of Cardiac Work in Heart Failure Patients

The VALIDATE Study of Valsartan for Patients With Early Stage Heart Failure